Spero Therapeutics (SPRO) Dividend Coverage Ratio (2017)
Spero Therapeutics' (SPRO) quarterly Dividend Coverage Ratio came in at 69.01 in Q3 2017.
Powered by 
Analysis
Spero Therapeutics (SPRO) Dividend Coverage Ratio (2017) Analysis & Trends
Spero Therapeutics (SPRO) has reported Dividend Coverage Ratio for 1 consecutive years, with 69.01 the latest figure, recorded in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Spero Therapeutics | 70.36 Mn | 19.58 Mn | - | - |